Back
Kymera Therapeutics Vs. Innodata Industry Stock Comparison
Sell
41
KYMR
Kymera Therapeutics
Last Price:
$40.48
Seasonality Move:
0.34%
Buy
63
INOD
Innodata
Last Price:
$43.93
Seasonality Move:
3.52%
Sell
41
Kymera Therapeutics (KYMR)
is a Sell
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $41.59. The Score for KYMR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
KYMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $41.59The current trend is relatively stagnant and KYMR is experiencing slight buying pressure.
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.3 | Sell |
Relative Strength Index (14 RSI): | 46.64 | Sell |
Chaikin Money Flow: | 69539 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.2 - 45.64) | Sell |
Bollinger Bands (100): | (42.69 - 48.79) | Sell |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.48 | Buy |
Relative Strength Index (14 RSI): | 57.39 | Buy |
Chaikin Money Flow: | 1235602 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.31 - 44.33) | Buy |
Bollinger Bands (100): | (14.45 - 38.63) | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.72 | Buy |
20-day SMA: | 41.93 | Sell |
50-day SMA: | 45.01 | Sell |
200-day SMA: | 41.27 | Buy |
8-day EMA: | 40.88 | Buy |
20-day EMA: | 41.92 | Sell |
50-day EMA: | 43.73 | Sell |
200-day EMA: | 41.06 | Buy |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.92 | Buy |
20-day SMA: | 40.73 | Buy |
50-day SMA: | 36.64 | Buy |
200-day SMA: | 19.33 | Buy |
8-day EMA: | 42 | Buy |
20-day EMA: | 40.96 | Buy |
50-day EMA: | 36.31 | Buy |
200-day EMA: | 22.92 | Buy |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and a decrease next year of $0.46 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.41 per share.
Kymera Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |